Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3WDB

N-terminal domain of Mycobacterium tuberculosis ClpC1

Summary for 3WDB
Entry DOI10.2210/pdb3wdb/pdb
Related3WDC 3WDD 3WDE
DescriptorProbable ATP-dependent Clp protease ATP-binding subunit, FORMIC ACID (3 entities in total)
Functional Keywordschaperone
Biological sourceMycobacterium tuberculosis
Total number of polymer chains1
Total formula weight16459.88
Authors
Vasudevan, D.,Noble, C.G. (deposition date: 2013-06-14, release date: 2013-09-18, Last modification date: 2023-11-08)
Primary citationVasudevan, D.,Rao, S.P.S.,Noble, C.G.
Structural basis of mycobacterial inhibition by cyclomarin A
J.Biol.Chem., 288:30883-30891, 2013
Cited by
PubMed Abstract: Cyclomarin A (CymA) was identified as a mycobactericidal compound targeting ClpC1. However, the target was identified based on pulldown experiments and in vitro binding data, without direct functional evidence in mycobacteria. Here we show that CymA specifically binds to the N-terminal domain of ClpC1. In addition we have determined the co-crystal structure of CymA bound to the N-terminal domain of ClpC1 to high resolution. Based on the structure of the complex several mutations were engineered into ClpC1, which showed reduced CymA binding in vitro. The ClpC1 mutants were overexpressed in mycobacteria and two showed resistance to CymA, providing the first direct evidence that ClpC1 is the target of CymA. Phe(80) is important in vitro and in cells for the ClpC1-CymA interaction and this explains why other bacteria are resistant to CymA. A model for how CymA binding to the N-terminal domain of ClpC1 leads to uncontrolled proteolysis by the associated ClpP protease machinery is discussed.
PubMed: 24022489
DOI: 10.1074/jbc.M113.493767
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.37 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon